Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer

Immune therapy is a promising field within oncology but has been unsuccessful in ovarian cancer (OC). Still, there is rationale and evidence supporting immune therapy in OC. We investigated the potential for adoptive cell therapy (ACT) from in vitro expanded tumor-infiltrating lymphocytes (TILs) in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Kverneland, Anders Handrup, Pedersen, Magnus, Westergaard, Marie Christine Wulff, Nielsen, Morten, Borch, Troels Holz, Olsen, Lars Rønn, Aasbjerg, Gitte, Santegoets, Saskia J., van der Burg, Sjoerd H., Milne, Katy, Nelson, Brad H., Met, Özcan, Donia, Marco, Svane, Inge Marie
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7275789/
https://ncbi.nlm.nih.gov/pubmed/32547707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27604
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados